PROMETHEUS BIOSCIENCES, INC. Accounts Receivable
PROMETHEUS BIOSCIENCES, INC. had Accounts Receivable of $1.03 million as of 2022-12-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-05-09
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.03M.
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $941.00K.
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.86M.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.29M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2022-12-31 | $1.03M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $941.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.86M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.29M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.08M 10-K · filed 2023-02-28 |
| 2021-09-30 | $679.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $217.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $973.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.09M 10-K · filed 2022-03-09 |